RedHill Biopharma (RDHL) Enterprise Value (QoQ) (2012 - 2023)
RedHill Biopharma (RDHL) Enterprise Value (QoQ) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -13.64% |
| Mar 31, 2023 | 12.00% |
| Dec 31, 2022 | 32.25% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 1.59% |
| Dec 31, 2021 | 42.73% |
| Sep 30, 2021 | 31.60% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -105.39% |
| Dec 31, 2020 | -6.20% |
| Sep 30, 2020 | 59.31% |
| Jun 30, 2020 | 1.92% |
| Mar 31, 2020 | -115.31% |
| Dec 31, 2019 | -2.67% |
| Sep 30, 2019 | 12.65% |
| Jun 30, 2019 | -0.21% |
| Mar 31, 2019 | -24.25% |
| Dec 31, 2018 | -4.93% |
| Sep 30, 2018 | -13.86% |